
|Podcasts|October 4, 2022
Transforming CMC Dossier Creation
Author(s)Dassault Systèmes BIOVIA
Through the adoption of a data driven and automated CMC Dossier generation process, pharmaceutical companies can reduce time-to-market while delivering significant cost savings to the organization. Eliminate errors, duplicate data entry and verification, create a digital chain of evidence and significantly reduce time spent on CMC authoring.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Trends Transitioning from 2025 into 2026
2
Building the Foundations for Proactive Drug Safety in 2026
3
Amgen Acquires UK Biotech Dark Blue Therapeutics
4
Genetic Medicines Project Gets Funding from UKRI Innovate UK and Canadian NRC IRAP
5



